SMLR Key Statistics, Chart & Performance
The current stock price of SMLR is 22.51 USD. In the past month the price increased by 17.12%. In the past year, price decreased by -65.2%.
SMLR Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.98 | 216.73B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.52 | 203.04B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.45 | 141.90B | ||
| SYK | STRYKER CORP | 27.44 | 138.20B | ||
| IDXX | IDEXX LABORATORIES INC | 57.48 | 57.87B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.3 | 48.17B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.93 | 39.58B | ||
| RMD | RESMED INC | 26.04 | 37.64B | ||
| DXCM | DEXCOM INC | 38.16 | 27.68B | ||
| PODD | INSULET CORP | 60.95 | 19.60B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.3 | 18.12B |
Related stock screener links
About SMLR
Company Profile
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Company Info
SEMLER SCIENTIFIC INC
51 E Campbell Ave, Suite 107-D
Campbell CALIFORNIA 97210 US
CEO: Douglas Murphy-Chutorian
Employees: 79
Phone: 18777744211
SEMLER SCIENTIFIC INC / SMLR FAQ
What does SEMLER SCIENTIFIC INC do?
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Campbell, California and currently employs 79 full-time employees. The company went IPO on 2014-02-27. The firm's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The firm delivers QuantaFlo directly to its customers. The firm also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.
Can you provide the latest stock price for SEMLER SCIENTIFIC INC?
The current stock price of SMLR is 22.51 USD. The price increased by 16.21% in the last trading session.
Does SEMLER SCIENTIFIC INC pay dividends?
SMLR does not pay a dividend.
What is the ChartMill technical and fundamental rating of SMLR stock?
SMLR has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting SMLR stock to perform?
9 analysts have analysed SMLR and the average price target is 66.98 USD. This implies a price increase of 197.56% is expected in the next year compared to the current price of 22.51.
What is the Price/Earnings (PE) ratio of SEMLER SCIENTIFIC INC (SMLR)?
The PE ratio for SEMLER SCIENTIFIC INC (SMLR) is 2.57. This is based on the reported non-GAAP earnings per share of 8.76 and the current share price of 22.51 USD.
When does SEMLER SCIENTIFIC INC (SMLR) report earnings?
SEMLER SCIENTIFIC INC (SMLR) will report earnings on 2026-02-16.
SMLR Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SMLR. When comparing the yearly performance of all stocks, SMLR is a bad performer in the overall market: 91.21% of all stocks are doing better.
SMLR Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to SMLR. While SMLR is still in line with the averages on profitability rating, there are concerns on its financial health.
SMLR Financial Highlights
Over the last trailing twelve months SMLR reported a non-GAAP Earnings per Share(EPS) of 8.76. The EPS increased by 220.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 130.8% | ||
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| Debt/Equity | 0.25 |
SMLR Forecast & Estimates
9 analysts have analysed SMLR and the average price target is 66.98 USD. This implies a price increase of 197.56% is expected in the next year compared to the current price of 22.51.
For the next year, analysts expect an EPS growth of -95.59% and a revenue growth -43.2% for SMLR